Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s):  VYYRF

Voyageur Pharmaceuticals Ltd. is a Canadian company, which develops barium, iodine and carbon active pharmaceutical ingredients. The Company is focused on producing its own barium, iodine and fullerene minerals. The Company, through its subsidiaries, Voyageur Industrial Minerals Ltd. and Voyageur Minerals Inc., is engaged in acquiring, exploring and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada and the state of Utah, United States. Its properties include Jubilee Mountain, Falcon and Paradox Basin. It owns a 100% interest in two barium sulphate (barite) projects, including the Frances Creek and Pedley Mountain property. It holds interests in a high-grade iodine, lithium, and bromine brine project situated in Utah, United States. It owns a 100% interest in two battery mineral projects that is focused on copper/zinc development. Its pipeline products include SmoothX 2.0%, MultiX Thick, MultiX Thin, HDX, LDX, VY-101 and VY-103.


TSXV:VM - Post by User

Comment by WarrantOfficeron Nov 21, 2020 8:39am
111 Views
Post# 31946572

RE:RE:RE:Investors Mislead

RE:RE:RE:Investors MisleadPostie1: I concur, no reason to sell off. It is the credability of management that is being brought into the limelight. Publically stating that Voyageur secures exclusive rights to one of the worlds rarest pharma minerals than back tracking and stating it does not and never had...that is just to big of a mistake not to be taken seriously. Brings forth the possibility further claims may not be as they seem. WIll have to closely monitor further PR's before considering further investment. I have not seen any insider sell offs. Patience required here to ensure they do not step on their own #$@*% again. 

 

<< Previous
Bullboard Posts
Next >>